Grow Everything Biotech Podcast

Karl and Erum kick off 2026 by reviewing their 2025 forecasts—celebrating the wins (DeSci's rise, waste as a resource, AI-biology convergence) and acknowledging the misses (no biotech M&A boom, no quantum biology breakthrough yet). Then they unveil their boldest predictions for the year ahead: the first functional AI-composed genome entering production, a major non-sterile biomanufacturing facility breaking ground, biological arbitrage creating competitive advantages against tariffs, consumer-held health records surpassing traditional medical data in clinical significance, space-manufactured drug crystals entering human trials, definitive proof of alien life, and AI-enabled communication with whales and other animals. They also welcome Lizette Couto, who joins the podcast to provide science definitions and explanations throughout episodes going forwa...

Karl and Erum kick off 2026 with deep reflections on prosperity, consciousness, and the idea that we might be living in a simulation. But the real focus is on a concept that could make or break biotech companies: orchestration. They dive into why most biotech innovations outside of pharma struggle to commercialize and introduce the idea of value chain syndication—bringing together innovators, manufacturers, investors, and big incumbents to create entire ecosystems rather than just individual deals. Using examples like K18 Hair's marketing orchestration and the urgent need to replace Red Dye 40, they break down how founders can architect strategic "seed deals" that build toward transformative industry shifts. This isn't about traditional sales or bu...

In this special holiday replay episode, we revisit our conversation with Ashley Beckwith, founder of Foray Biosciences, who shares her groundbreaking work in plant cell culture and tissue engineering. Growing up in Colorado, Ashley watched forests disappear to housing development and wildfire—experiences that sparked her lifelong mission to reimagine how we produce plant materials. After training as an engineer and working in medical device development, she pivoted to apply tissue engineering concepts to plants, initially exploring lab-grown wood before discovering a more fundamental problem: the lack of accessible, efficient plant cell culture processes. Today, Foray develops fabricated seeds for forest restoration, creates harvest-free plant products, and builds AI-powered tools to accelera...

In this episode, Karl and Erum speak with Aradhita Parasrampuria, founder of CellSense, about revolutionizing the fashion embellishment industry through biology. Aradhita shares her journey from witnessing toxic dye masters in Gujarat textile factories to creating biodegradable sequins, beads, and buttons using algae and bacterial cellulose. She explains how her materials can be produced at room temperature, glow in the dark through bioluminescence, and are manufactured through an automated system that eliminates exploitative manual labor. With one in five garments containing embellishments, CellSense addresses a massive market while tackling microplastic pollution, worker health issues, and the 2027 EU ban on microbeads and lead. Aradhita discusses successful pilots with fashion brands and skincare companies...

Karl and Erum explore the untapped potential of fungi through three groundbreaking interviews. First, they speak with Susanne Gloersen, founder of the Future is Fungi Award, about why fungi represent the next frontier in biotech and how her global platform is accelerating fungal innovation across industries—from soil remediation to firefighting foam. Next, they sit down with Ricky Cassini of Michroma, winner of the Future is Fungi Award, who explains how his team engineers fungi to produce natural food colorants that outperform synthetic dyes and plant-based alternatives, offering 50x more potency than traditional options while being heat and pH st...

Lauryn Menard, co-founder of Gob, joins us to discuss how she's tackling the 40 billion petroleum-based earplugs produced annually by creating the first biodegradable, mycelium-based alternative. Named one of Fast Company's Most Innovative Companies of 2025 and featured in Time Magazine's Best Inventions, Lauryn shares her journey from industrial designer to biotech entrepreneur. She explains why she chose mycelium over other biomaterials, how she scaled production without building a factory from scratch, and her strategy for bringing sustainable products to mainstream consumers through cultural relevance—partnering with artists like Billie Eilish and Chappell Roan at major music venues. Lauryn also reveals he...

In this Thanksgiving replay, we revisit our conversation with Paul Shapiro, co-founder and CEO of Better Meat Co, who's pioneering the use of mycelium-based proteins as a sustainable alternative to animal meat. Paul shares his remarkable journey from starting an animal welfare organization in high school to becoming a biotech entrepreneur. He explains how fungi fermentation creates protein-rich, meat-like textures in less than 24 hours without the environmental toll of traditional agriculture. The episode explores the science behind mycoprotein, the challenges facing the alternative protein industry, the need for government investment in biomanufacturing, and why fungi may be the key...

Join us for a mind-bending conversation with Professor Michael Levin, director of the Allen Discovery Center at Tufts University, as he reveals how cells make decisions without brains, store memories without DNA, and navigate anatomical space like we navigate physical space. Discover how his team created two-headed immortal worms whose memory persists across regeneration cycles, how bioelectrical patterns control body shape independently of genetics, and why the future of medicine lies in communicating with the collective intelligence of our cells rather than micromanaging their molecular machinery. From xenobots made of frog cells to the anatomical compiler that will revolutionize...

We sit down with Andrew Verbinnen, founder of HairDAO, who's revolutionizing how we approach hair loss research and treatment. After experiencing hair loss himself at nineteen, Andrew discovered that androgenetic alopecia - affecting 95% of hair loss cases - receives almost no funding because it's classified as cosmetic rather than a disease. By creating a patient-led biotech organization combining a thriving online community with an in-house high-throughput lab, HairDAO has driven research costs down from $250,000 per study to just $6,000 while accelerating results from two years to one month. Andrew shares how they've developed proprietary treatments available through their telehealth platform...

Karl and Erum sit down with Gabe Tavas, CEO and co-founder of Symmetry Wood, who is pioneering a revolutionary approach to wood production. Gabe shares his journey from design student to bio-innovator, inspired by his time volunteering in rural Ecuador where he witnessed the devastating impact of plastic waste. His company has developed Pyrus, the first solid wood made primarily from bacterial nanocellulose—specifically, waste from the world's largest kombucha brewery. Instead of logging endangered tropical hardwoods, Symmetry Wood is targeting the high-end guitar industry first, proving that biodesigned materials can meet the most demanding performance standards. Gabe discusses th...

In this Halloween-themed episode, Veronica Breckenridge from First Bite returns to discuss her eye-opening "Industrial Bio-Manufacturing Graveyard Report." Drawing from her experience scaling companies like Apple and Tesla, Veronica reveals why 80% of bio-manufacturing startups fail—and it's not because of bad science. The conversation explores critical mistakes like targeting commodity markets too early, underestimating downstream processing costs, and the "build it and they will come" mentality that has buried promising ventures. Veronica explains why now is actually the best time to invest in bio-manufacturing, citing decreasing costs (3 million times cheaper in 25 years), rising consumer demand for healthier alternatives to pe...

In this episode, we explore how Varda Space Industries is pioneering pharmaceutical manufacturing in microgravity with Chief Strategy Officer Michael Riley and Chief Science Officer Adrian Radocea. The team discusses how removing gravity from the crystallization process enables better drug formulations—creating more stable, bioavailable medicines that don't require refrigeration. From their reusable spacecraft that can manufacture drugs in orbit and return them to Earth, to their vision of making space-based manufacturing routine and "boring," Varda is bridging aerospace engineering and biopharma to solve formulation challenges that have stumped the industry for decades. With $187 million in recent funding and sp...

In this episode, Erum and Karl unpack six major reports that define the current state of synthetic biology and the bioeconomy. From investment trends to national security concerns, from manufacturing failures to trillion-dollar opportunities, these reports paint a complex picture of an industry at a critical turning point.

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?

Learn more at ⁠www.messaginglab.co...

In this special 150th episode of Grow Everything, Erum and Karl broadcast live from the BioFab Fair 2025 in London. They explore the innovative world of biology as technology with special guests Elliot Roth and Amanda (from Mothership Materials), discussing community biotech labs, biopunk culture, and sustainable feedstocks for the bioeconomy.

Chapters:

This episode explores the journey from scientific breakthrough to scalable industrial implementation. Phil Morle — partner at Main Sequence and co‑founder of Pollenizer — explains how strategic off‑takes generate market pull, the reasons nylon recycling advanced faster than PET, and the orchestration techniques required to progress from First-Of-A-Kind (FOAK) to Next-Of-A-Kind (NOAK) facilities. The conversation covers practical aspects of costs, partnership development, policy incentives, and industrial realities, including Phil's pragmatic test: "if it doesn't need a forklift, it's not relevant."

Chapters:

In this episode of Grow Everything, hosts Karl Schmieder and Erum Azeez sit down with Dr. Alessandra Zonari, co-founder and Chief Scientific Officer at OneSkin. Alessandra shares her personal journey from Brazil to biotech, driven by a mission to transform how we think about aging. She explains the science of cellular senescence, the discovery of the groundbreaking OS-1 peptide, and why skin is more than a beauty surface—it’s a window into systemic health and longevity. Listeners will hear candid insights into the challenges of translating biotech discoveries into consumer products, the importance of radical transparency in science comm...

What if we could treat debilitating diseases by listening in on the "secret, invisible language" of worms? In this groundbreaking episode, we talk with Dr. Andrea Choe, Co-Founder and CEO of Holoclara, who uncovered a "universal worm language" used for hundreds of millions of years. Dr. Choe reveals how our modern "aggressive hygiene routine" removed the worms we co-evolved with, leading to a rise in allergic and autoimmune diseases. Discover how her team is pioneering a new class of safe, orally available therapies by synthesizing worm-derived molecules that "rebalance" our immune systems and have already blocked disease in animal...

In this episode of Grow Everything, hosts Karl Schmieder and Erum Azeez talk with Benji Leibowitz, Co-Founder of Pump Science, about what it really means to be “DAO-ing science differently.” From the early days of Molecule DAO to today’s crypto-native platform for funding longevity and nootropics research, Benji explains how decentralized science (DeSci) can rebuild healthcare and biotech from the ground up. By combining bonding curves, tokenized IP, and radical transparency with live-streamed worm and fly experiments, Pump Science is transforming science into an attention game that’s fast, fun, and open to everyone. Tune in to hear how DAO...

In this highlight reel episode of Grow Everything, hosts Erum Azeez and Karl Schmieder dive deep into the rapidly evolving world of decentralized science (DeSci). Featuring expert insights from Albert Anis, Jocelyn Pearl, Michael Fisher, and Laura Minquinin, this episode explores how DeSci is revolutionizing the way research is funded, shared, and governed — far beyond traditional academic systems. You’ll hear how blockchain, bioDAOs, and decentralized funding models are enabling faster, more collaborative innovation across the life sciences. Whether you're a researcher, founder, or biotech enthusiast, this conversation unpacks the tools, values, and infrastructure reshaping the future of scientific disc...

Karl Schmieder and Erum Azeez sit down with Karen Ingram, Creative Director & Designer at Karen Ingram & Associates, Inc. From her iconic Biogenetic Blooms—Petri dish paintings made with living yeast—to her innovative teaching with BioBuilder and playful experiments like Fallacy Bingo, Karen shows how science and creativity can merge to inspire broader engagement with biotechnology. She shares stories from the early Brooklyn biohacker days, reflects on teaching teenagers to think critically about designing life, and explains how art, games, and design can shape the future of the bioeconomy. This is where art truly meets agar—transforming living microbes into c...

Hosts Karl Schmieder and Erum Azeez sit down with Dr. Kyle Landry, President and Co-founder of Delavie Sciences, to explore how extremophiles—microbes that survive in the harshest environments on Earth and space—are unlocking new frontiers in skincare and longevity. Kyle shares his unconventional path from food science to biodefense to NASA collaborations, revealing how a microbe that survived 18 months outside the International Space Station became the foundation for a groundbreaking sunscreen ingredient. The conversation dives into longevity science, microbial resilience, the future of skincare as true preventative health, and the entrepreneurial challenge of scaling biotech innovations from test...

Karl and Erum speak with Richard Traherne of Capgemini Invent and Cambridge Consultants, where they explore the explosive convergence of engineering biology, artificial intelligence, and sustainable innovation. Richard reveals how programmable biology is catalyzing a new industrial revolution—transitioning biotech from niche innovation to foundational infrastructure across sectors like food, fashion, personal care, and manufacturing. From building predictive bio-labs to deploying proprietary large language models for enzyme design, Richard shares how his team is helping companies leap from conceptual curiosity to commercial readiness. The conversation dives into challenges faced by both bio-literate and bio-novice enterprises, the importance of storytelling an...

In this episode of Grow Everything, Erum sits down with Momo Vuyisich and Guruduth (Guru) Banavar of Viome to explore how decoding the human microbiome could transform the way we understand and treat disease. From the depletion of beneficial gut bacteria to the cutting-edge use of AI in precision health, Momo and Guru share how Viome’s technology turns deep biological insights into actionable, personalized health recommendations. Along the way, they connect the dots between gut science, chronic illness prevention, and the massive opportunity for biomanufacturing to deliver scalable wellness solutions. This is a conversation that blends molecular biology wi...

In this special episode of Grow Everything, hosts Karl and Erum pull back the curtain on their own operations, offering a behind-the-scenes look at how the podcast came to life. They discuss the core mission of sharing innovative bioengineering breakthroughs, the challenges of maintaining a weekly podcast, and the team behind it all. From the technical intricacies of biomanufacturing to the strategic communications needed to make those breakthroughs accessible to a wider audience, this episode reflects on the journey, growth, and impact of the Grow Everything platform. With a mix of humor and passion for sustainability, Erum and Karl...

In this episode of Grow Everything, hosts Karl and Erum dive into the world of community biology with Dr. Casey Lardner, Executive Director of Genspace. They explore how this groundbreaking Brooklyn lab is reimagining who gets to participate in science — and how. From radical accessibility and inclusive education to the launch of Gotham Foundry, Casey shares how Genspace is cultivating a culture of curiosity, creativity, and collaboration. This is a conversation about science as a shared resource, where artists, bioengineers, and everyday citizens all have a seat at the bench.

Grow Everything brings the bioeconomy to life. Ho...

In this thought-provoking episode of Grow Everything, host Karl sits down with Suzanne Lee, founder of Biofabricate and pioneer in the biomaterials revolution, for a conversation that redefines how we think about material innovation. With passion and precision, Suzanne shares her journey from fashion design to biodesign, revealing how her early experiments with growing microbial cellulose led to the launch of a global movement toward sustainable, biology-based materials. They explore how biology and culture are converging, why “natural” doesn’t always mean better, and how collaboration—not competition—is key to transforming industries like fashion, architecture, and consumer goods. If you're...

In this episode, Karl and Erum sit down with Shelby Newsad, Partner at Compound, to unpack the explosive rise of consumer biotech, biohacking, and radical health optimization. Shelby shares inside stories from Compound’s Biohacker Demo Day, exploring how crypto funding, accessible blood testing, and personal health data are reshaping the future of healthcare. From peptides and proteome sequencing to fire-breathing dragons and continuous glucose monitors, this conversation dives deep into how individuals are reclaiming agency over their biology. If you’re fascinated by the intersection of synthetic biology, longevity, and culture, this is a must-listen.

Grow Ever...

Karl and Erum bring on Dr. Alexander Titus, a commissioner on the National Security Commission on Emerging Biotechnology, to explore the exciting and challenging intersections of biotechnology and policy. Alexander shares his experiences from his unique journey across academia, government, and industry, diving into the role of biosecurity, the potential of synthetic biology, and the emerging convergence of tech and bio. They discuss ambitious projects like de-extincting the woolly mammoth, advances in biodefense, and the impacts of AI on biotech innovation. It’s a conversation that sheds light on how cutting-edge biotech could shape the future and the necessary ba...

Karl and Erum sit down with Elle Black, a product designer and manufacturing strategist whose journey into the world of skincare, AI, and biology is anything but typical. Elle shares how her background in physical product development led her to dive deep into the supplement and cosmetics industries—spaces rich with opportunity and riddled with misinformation. From decoding the intricacies of INCI labeling to navigating unregulated beauty markets, she unpacks what it really takes to build responsible, scalable consumer products. Whether you're in biotech, product innovation, or sustainability, Elle's perspective on building smarter—from ingredients to algorithms—will resonate.

G...

Karl and Erum are joined by Nancy Diniz, Co-Founder of bioMATTERS LLC, to explore the future of biodesign and sustainable materials. Drawing on her background in architecture and digital fabrication, Nancy unpacks how bioMATTERS is creating novel mycelium- and microbe-based materials that are not only biodegradable but alive. The conversation traverses speculative design, the challenge of scaling living materials, and the cultural shift needed to embrace biology as a partner in production. With humor and insight, Nancy shares how her work sits at the intersection of art, science, and ecology—and why the next generation of materials must be ro...

Karl and Erum speak with Dr. Angela M. Belcher, MIT professor and pioneer in bioinspired materials, about how biology can transform the way we manufacture sustainable technologies. Drawing inspiration from how abalone build shells and viruses assemble structures, Angela shares how her lab uses genetically engineered viruses—like M13 bacteriophage—to grow batteries, solar cells, and cancer-targeting materials at room temperature without harmful chemicals. Her work reimagines the periodic table as a design toolkit and shows how nature’s strategies can help us build cleaner, smarter, and more sustainable solutions.

Grow Everything brings the bioeconomy to life. Hosts...

Karl and Erum sit down with Erika Milczek, CEO and founder of Curie Co, to explore how synthetic biology is rewriting the rules of modern chemistry. Erika, a former Merck chemist, shares her journey from Big Pharma to launching a biotech startup that engineers enzymes to replace legacy chemicals in personal care and consumer goods. With insights grounded in regulatory shifts, manufacturing scalability, and the power of directed evolution, Erika discusses how her team is building a “biotech alternative to petroleum-based chemistry.” Whether you're curious about enzyme engineering, bioindustrial startups, or how synthetic biology can drive sustainability in everyday prod...

Karl and Erum are joined by Dr. Ashley Beckwith, Founder & CEO of Foray Bioscience, for a wide-ranging conversation on the future of biomaterials and the emerging role of plant culture in shaping it. Ashley unpacks how Foray is pioneering new approaches to growing materials directly from plant cells, redefining how we produce, restore, and preserve biological resources.

The episode explores the untapped potential of plant culture in bioproduction, ecosystem restoration, and biodiversity preservation when applied with care and intention. Ashley shares her path from growing up in Colorado to pursuing mechanical engineering and bioengineering, and how that...

In this energetic recap of SynBioBeta 2025, Erum and Karl bring listeners straight into the heart of the year’s most important synthetic biology gathering. From Drew Endy’s visionary keynote on distributed, localized manufacturing to the ever-present theme of AI as the enabler of hyperscale biology, this episode unpacks the biggest ideas shaping the future of biomanufacturing and materials innovation. The duo reflect on how the conference architecture—from hallway conversations to main stage moments—facilitated cross-disciplinary collisions and bold discussions about biology as the foundational infrastructure of the 21st century. Whether you're a bioengineer, startup founder, or investor, this deb...

Erum sits down with Michael Heltzen, CEO of eXoZymes, to dive into the transformative world of cell-free biomanufacturing. Michael shares the origin story of ExoZymes—from a student bioengineering dream at UCLA to ringing the NASDAQ bell—and unpacks why scalability, sustainability, and design thinking are central to the next generation of biotech. If you're curious about how biology can be engineered without living cells, what it takes to commercialize breakthrough science, or how new business models in synthetic biology are emerging, this is the episode for you. Get ready to rethink what’s possible when biology breaks free from t...

Karl and Erum revisit their energetic and unfiltered recap of SynBioBeta 2024. With candid reflections on the conference and the broader synthetic biology ecosystem, they spotlight key trends including the rise of accessible community bio labs, decentralized events like the Biopunk gathering, and the convergence of deep tech and culture. This is not your average event recap—it's a tour through the evolving architecture of the bioeconomy, from the mainstream to the fringes. Whether you missed the event or want to relive the highlights, this episode captures the pulse of where biotech is heading.

Grow Everything brings the bi...

Erum and Karl break down a concept they've lived and breathed—but rarely spelled out: orchestration. If you're building a startup in synthetic biology or advanced materials, this is a must-listen deep dive into how influence is built before your product lands or your funding closes. They pull back the curtain on how to create "value chain syndicates," why intros aren’t just intros, and how real biotech momentum comes from aligning stakeholders across an entire ecosystem—not just impressing one customer.

Taped just ahead of SynBioBeta 2025, this episode crackles with tactical wisdom, from designing credibility scaffolds to cre...

Karl and Erum reconnect with Eben Bayer, Board Chair at MyForest Foods, for a compelling follow-up conversation on the evolution of mycelium-based food products. Eben dives deep into the scaling journey of MyBacon, a plant-based bacon alternative created through solid-state fermentation using gourmet mushroom mycelium. From early experiments producing just six packs a week to now operating at multiple farms across North America and Europe, Eben outlines the technical, economic, and operational hurdles his team has overcome. Listeners will discover how MyForest Foods is pioneering a distributed, farm-based manufacturing model and why MyBacon is outpacing pork bacon in select...

Karl and Erum welcome back Dr. John Cumbers—founder of SynBioBeta and Biological Enlightenment Studios—to dive deep into the transformative power of synthetic biology. From designing personalized proteins and sustainable materials to programming life for space exploration, John unpacks why synthetic biology could be the defining technology of our century. The conversation spans the central dogma, programmable cells, AI-designed genomes, and even the ethics of growing brainless human clones. With themes ranging from planetary health to Pixar-style science storytelling, this episode offers a biologically enlightened vision of a future where we grow everything—from meat to materials to machin...

What if you could grow health-boosting compounds—not in fields, but in bioreactors—using the power of plant cells? In this episode, Karl and Erum sit down with Ilan Sobel, CEO of BioHarvest, to explore how the company is reshaping biotech, nutraceuticals, and biomanufacturing. From leveraging botanical synthesis to create highly bioavailable compounds like piceid resveratrol, to scaling sustainable DTC operations that rival software margins, Ilan reveals how BioHarvest is closing the gap between nature, science, and commerce. Hear how this Coca-Cola veteran is building a biological infrastructure poised to disrupt pharma, food, and beyond—one cell at a time.<...

In this episode of Grow Everything, Karl and Erum dive deep into the transformative world of biomanufacturing with Molly Morse, CEO and Co-founder of Mango Materials. Molly shares how her team is using methane—one of the most potent greenhouse gases—as a feedstock to create PHAs, a class of biodegradable bioplastics. From wastewater treatment partnerships to collaboration with brands like Allbirds and Stella McCartney, Mango Materials is setting a new standard in sustainable innovation. The conversation spans synthetic biology, microbial fermentation, the challenges of scaling, and even bioplastics in space. If you're passionate about circular economies, advanced materials, or c...

Karl and Erum sit down with Daniel Goodwin, co-founding Director of Homeworld Collective alongside his friend and collaborator Paul Reginato. Together, they explore how to build resilient, values-aligned infrastructure for a flourishing bioeconomy—beyond the venture model.

From climate biotech to systems thinking, Daniel shares how Homeworld Collective is more than just a network—it's an emergent, mycelial community focused on care, collaboration, and collective intelligence. The conversation weaves through everything from the limits of "techno-solutionism" to the power of story in science, and the need to design not just tools, but the conditions for innovation to thri...

Erum and Karl dive into the fascinating world of the skin microbiome with Natalie Enslow, CEO and co-founder of Fjor. Natalie shares her journey from marketing to biotech, explaining how her brand is revolutionizing skincare by embracing the power of beneficial bacteria. She discusses the importance of microbial diversity, the challenges of launching a biotech-driven skincare brand, and how Fjor's enzyme-powered formulations are designed to support rather than replace the skin’s natural microbiome. The conversation also touches on the future of gender-neutral skincare, the intersection of biotech and entrepreneurship, and why the beauty industry needs a serious science-backed sh...

Karl and Erum sit down with Veronica Breckenridge, founder of First Bight Ventures, to discuss how the convergence of biology and technology is driving the biggest innovations of the 21st century. Drawing from her deep tech background, including her time at Apple, Veronica explores rapid advancements in genome sequencing, AI-driven biotech, and the vast untapped potential of microbes, emphasizing why now is the time to harness biology to tackle global challenges in health, nutrition, sustainability, and manufacturing. From synthetic biology startups to biomanufacturing at scale, this episode delves into the future of biomaterials and how venture capital can accelerate...

Karl and Erum sit down with Massimo Portincaso, founder of Arsenale BioYards, to discuss the urgent need to rethink how we scale biomanufacturing. Massimo shares why today’s approach to industrial biotech—modeled after biopharma—is fundamentally flawed and how Arsenale is flipping the script. From nature co-design to AI-driven strain selection, he lays out a bold vision for scaling bio-based production in a way that is economically viable and industrially scalable. If you care about the future of precision fermentation, sustainable materials, and the bioeconomy, this is a conversation you don’t want to miss!

Learn...

Flavors, fragrances, and the science behind what makes things smell and taste amazing—Karl and Erum explore this world with Bob Weinstein, a legend in the industry who has spent decades at Firmenich, Robertet, and now Bedoukian Research. Bob takes them on a journey from the early days of animal-derived scents (yes, civet was a thing) to the rise of biotech-powered ingredients that are shaping the future of sustainable fragrance and flavor. They get into the art and science of scent, the challenges of scaling biomanufacturing, and why companies, much like organisms, have to evolve to survive. Plus, Erum sh...

In this episode of Grow Everything, Karl and Erum sit down with Dr. Glennis Mehra, the absolute powerhouse behind BioLabs at NYU Langone, to talk about what it really takes to build a biotech startup in New York City. From how to deal with imposter syndrome to finding funding in a capital-constrained world, Glennis shares hard-earned insights on how founders can survive (and thrive) in one of the toughest, most exciting biotech ecosystems on the planet. They get into the magic of founder-to-founder collaboration, why biology’s complexity is finally getting the respect it deserves, and whether AI is ab...

Erum and Karl get into the nitty-gritty of evolution, automation, and space microbes with Erika DeBenedictis—CEO of Pioneer Labs, a computational physicist, molecular biologist, and all-around biotech explorer. They chat about her wild career path from JPL and Sandia National Laboratories to engineering microbes for Mars and running an academic lab dedicated to Robotics-Accelerated Evolution (yes, that’s as cool as it sounds). You can expect to hear all about AI-driven protein design, the future of fully automated science, and why programmable experiments might just be the next CRISPR. Plus, a little existential musing on whether life on Eart...

In this special Grow Everything episode swap with The Climate Biotech Podcast, Erum and Karl introduce a mind-blowing conversation with the one and only George Church. If you’re into synthetic biology, you already know he’s a legend—co-founding 50+ biotech companies and pushing the boundaries of what’s possible with DNA. In this episode, George talks about scaling microscopic innovations to solve massive global challenges—think rewilding ecosystems, bio-mining for new molecular tools, and engineering biology to fight climate change. He even throws out wild ideas like testing space colonies on Earth before heading to Mars. Stick around after the...

Doug Friedman joins the podcast to talk about one of the toughest challenges in biotech—how to survive long enough to actually make an impact. As the head of BioMADE, he's on a mission to build a bioindustrial manufacturing ecosystem that doesn’t just rely on wishful thinking and a single grant check. He explains why most biotech startups get only "one shot on goal" (spoiler: they miss, they’re done) and how we can fix that. Think of it like debugging a bad DNA sequence—you need iteration, not instant perfection. Doug also discusses how government funding is shaping...

Noah Helman, co-founder of Industrial Microbes, unpacks how his team is giving ethanol a glow-up as a renewable feedstock for creating advanced polymers and sustainable carbon fibers. With a decade of experience in the trenches of biomanufacturing, Noah discusses how they’re engineering microbes to work smarter, not harder, tackling the challenges of cost, scale, and environmental impact. From leveraging industrial partnerships to envisioning a future where waste becomes the ultimate raw material, Noah delivers sharp insights with a side of microbial magic, proving that biology is not just life—it’s a powerhouse of innovation.

Grow Everyt...

Erum and Karl have an incredible chat with Nick Edwards, the innovative mind behind Potato AI. Nick goes into the inspiration behind the platform's unique name, rooted in childhood curiosity and scientific wonder, and shares his journey from neuroscience research to building a groundbreaking tool aimed at accelerating scientific discovery. He explains how Potato tackles the overwhelming deluge of scientific literature and the reproducibility crisis using AI to structure and analyze data in transformative ways. With stories from his own career, a stint in consulting, and running his podcast "Once a Scientist," Nick discusses the future of AI, science...

Karl and Erum welcome Dr. Chris Mason. He’s a professor of genomics, physiology, and biophysics, as well as co-founder / COI of BiotiaNYC, Ursa Bio, and Onegevity. Chris will take you on a journey from the mysteries of space genomics to the hidden worlds of Earth's microbiomes. He discusses the intersection of advanced biology and space exploration, diving into his work with NASA’s twin study, the possibilities of planetary engineering, and his fascination with unknown DNA found even in urban subways. Chris also talks about how the convergence of ancient biological knowledge and cutting-edge technology could redefine humanity's futu...

Karl and Erum give us a peek into their outlook for 2025, discussing biotech trends, the rise of decentralized science, and the convergence of AI with biology. They talk about the thawing of the "biotech winter," the potential risks of a new bird flu pandemic, and exciting innovations in quantum biology and drug discovery. Their conversation also touches on how waste can become a resource in biomanufacturing, the future of microbiome engineering, and the growing visibility of biotech in mainstream media. Tune in to hear Karl and Erum set the stage for an exciting year ahead in the world of...

Karl and Erum welcome Niklas Anzinger, the visionary founder of Vitalia, a decentralized city aimed at revolutionizing biotech and longevity. Niklas discusses the need for a more efficient drug development process, proposing a shift toward safety trials and medical reciprocity that could drastically shorten the time it takes to bring life-saving therapies to market. He talks about how Vitalia serves as a hub for biotech innovation, where companies can thrive outside traditional bureaucratic constraints. Niklas shares his ideas on medical freedom and the importance of allowing individuals to make informed choices about their health. He critiques the paternalistic nature...

Kevin Flyangolts joins Erum and Karl to talk about the evolving landscape of biosecurity. They discuss the rapid advancements in biotechnology, the growing accessibility of synthetic DNA, and the need for robust screening systems to ensure safety in the bioeconomy. Kevin shares knowledge from his software background, explaining how tools like those at Aclid Bio are bridging gaps in security, protecting against potential misuse, and setting the stage for future innovations in biotech. With reflections on government initiatives, industry collaboration, and the complexities of ethical biosecurity practices, this conversation showcases the urgent issues and exciting possibilities in the intersection...

Andy Bass brings the ocean's glow to your hands, turning natural wonders like bioluminescent plankton into personal and immersive experiences. From creating the Dino Pet to designing ocean-bathing exhibits, Andy shares how biology can light up creativity, spark curiosity, and inspire the next generation of conservationists. It's a conversation about the intersection of nature, imagination, and the transformative power of "living art."

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it...

Andy Bass brings the ocean's glow to your hands, turning natural wonders like bioluminescent plankton into personal and immersive experiences. From creating the Dino Pet to designing ocean-bathing exhibits, Andy shares how biology can light up creativity, spark curiosity, and inspire the next generation of conservationists. It's a conversation about the intersection of nature, imagination, and the transformative power of "living art."

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it...

Karl and Erum are taking us deep into the intersection of biology, industry, and innovation with their guest, Jason Kakoyiannis. Jason is the founder of Bioscentric, advisor at Allonnia, and managing partner of Ferment! From starting his journey in the art world to leading the charge at Ferment, Jason shares how curiosity and the drive to solve complex problems led him to build a venture studio focused on market-driven biotech solutions. They discuss how biology can unlock sustainable answers to big challenges, like optimizing energy systems or creating eco-friendly alternatives in manufacturing. Along the way, Jason explains how his...

Join Karl and Erum in this special Thanksgiving replay of Aaron Schacht’s episode as they revisit this fascinating conversation. Aaron is the CEO & Board Director of BiomEdit and he has a visionary approach to leveraging microbiome science and synthetic biology to tackle some of the biggest challenges in animal health. Whether it’s creating healthier livestock, addressing sustainability issues, or revolutionizing methane reduction in agriculture, this episode covers it all.

As Karl and Erum reflect on the year, they share what they’re thankful for before introducing Aaron’s episode. BiomEdit’s innovative strides, led by Aaron, let...

Karl and Erum welcome computational biologist and artist Elizabeth Henaff to talk about the invisible yet vital world of microbiomes in urban settings. Elizabeth discusses the fascinating interplay between microbes and city life, explaining how DNA sequencing brings out hidden microbial stories in spaces like subway stations, waterways, and even beehives. The conversation goes into how design decisions influence microbial ecosystems, the surprising microbial diversity in cities, and the potential of art and science to shape a healthier, more sustainable urban future. This episode invites listeners to rethink their relationship with the unseen living world around them.

...

Karl and Erum bring on Dr. Alexander Titus, a commissioner on the National Security Commission on Emerging Biotechnology, to explore the exciting and challenging intersections of biotechnology and policy. Alexander shares his experiences from his unique journey across academia, government, and industry, diving into the role of biosecurity, the potential of synthetic biology, and the emerging convergence of tech and bio. They discuss ambitious projects like de-extincting the woolly mammoth, advances in biodefense, and the impacts of AI on biotech innovation. It’s a conversation that sheds light on how cutting-edge biotech could shape the future and the necessary ba...

Karl and Erum sit down with Moji Karimi, co-founder of Cemvita, a company innovating in carbon conversion technology. Moji shares details of Cemvita’s journey from an ambitious vision of industrial biotechnology to solutions that turn carbon emissions into valuable products. Moji talks about the science and impact of reshaping industries like energy, mining, and aerospace, pointing out how important it is to use nature’s processes to advance sustainability. Tune in to learn about the evolving relationship between biotech and heavy industries; a future where carbon waste becomes a resource.

Grow Everything brings the bioeconomy to life...

Rocky Graziose from The Estée Lauder Companies is here to discuss the innovative intersection of biotechnology and beauty. With a background in plant natural products chemistry, Rocky brings an insider perspective on how Estée Lauder is pushing boundaries in skincare and cosmetics. He talks about the evolution of the beauty industry and how The Estée Lauder’s Companies commitment to sustainability through biotechnological advancements like precision fermentation. From pioneering skincare routines to developing bioengineered ingredients that are more effective and environmentally friendly, Rocky is giving us all a look into the future of beauty. Tune in to he...

In this milestone 100th episode, Karl and Erum look back on collaborations like the biosecurity event with Andrew Hessel and the U.S.-India Next Gen Materials event, while also acknowledging the establishment of the Chumash Heritage National Marine Sanctuary. Erum and Karl are also joined by special guest Dan Grushkin to explore the evolving world of biotechnology and its impact on society. They talk about biosecurity, democratized DNA synthesis, and the intersection of science and creativity. Dan shares how he went from founding Genspace to launching the Biodesign Challenge, discussing the importance of community-driven science and the integration...

Erum and Karl reflect on their journey of producing nearly 100 episodes over two years. They discuss the challenges of consistency, the behind-the-scenes work required, and the evolution of their podcast from a simple idea to a platform that amplifies voices in the biotech space. Highlights include their gratitude to guests and collaborators, feedback from listeners, and the growing impact of their conversations, which now extend beyond audio, into video content and live events. As they look forward to the next 100 episodes, Erum and Karl express excitement about continuing to explore the frontiers of biotechnology and science communication!

...

Yuji Suzuki shares his journey from economics to leading a biotech company at the forefront of microbial research. He explains how bitBiome is unlocking the potential of trillions of microbes using advanced sequencing technology, and how their work could reshape industries from pharmaceuticals to sustainability. Yuji also dives into the future of biotechnology, the challenges of working with microbial data, and the importance of global collaboration. This conversation offers a clear look at the exciting intersection of biology, technology, and innovation.

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories...

Karl and Erum are taking us into the world of biohacking, discussing its various definitions and practices, from simple lifestyle changes to more extreme measures like genetic modification. They dig into the growing movement toward improving health, longevity, and human performance, touching on biohacking pioneers like Brian Johnson. Their conversation includes insights on the ethical and societal implications of biohacking that are really thought-provoking, as well as how technology and biotechnology are pushing the boundaries of human potential. Don’t miss it!

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share st...

Karl and Erum welcome Christina Smolke, CEO of Antheia and Professor at Stanford University, to discuss the rapid changes happening in biotech, particularly focusing on the biohacking community and decentralized science (DCI). Christina is developing revolutionary ways to manufacture critical pharmaceuticals using biotechnology. They explore the intersection of biohacking, pharmaceuticals, and emerging technologies. A key theme is the potential of biological processes to transform traditional methods, such as growing plants for medicine, into faster, scalable alternatives. Karl, Erum, and Christina talk about cutting-edge topics like longevity, decentralized research, and biotech’s growing role in addressing global challenges such as dr...

Christina Agapakis from Ginkgo Bioworks joins the conversation to explore the power of storytelling in science. She goes into the challenges scientists face when communicating their work to the public and the role effective messaging plays in shaping perceptions, especially around complex topics like GMOs and synthetic biology. Christina shares her journey and insights from her time at Ginkgo, and thoughts on how biotech can drive solutions for climate change and the future. Tune in to hear how science and communication intersect in shaping the biotech world.

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder...

Erum and Karl sit down with Vega Shah from NVIDIA to explore the role of AI in healthcare and life sciences, and how it's driving major advances in drug discovery and biotechnology. Vega shares real-world examples, from lab-grown cotton to using AI to discover new proteins in the gut microbiome. She also discusses the challenges of modeling complex biological systems and how tools like generative AI are changing the way we approach these problems. This episode is a look at how cutting-edge tech, with NVIDIA at the forefront, is making biology more accessible and impactful.

Grow Everything...

Astronaut and molecular biologist Dr. Kate Rubins shares her groundbreaking work on the International Space Station, from being the first to conduct DNA sequencing in space to advancing biotechnology in a unique and challenging environment. Dr. Rubins explains how space affects biological processes, the tools being developed to study these effects, and how these advancements could revolutionize industries on Earth. Her insights into the future of space travel and exploration, including the potential for sustainable life on Mars, offer a glimpse into the exciting intersection of biology and space science.

Grow Everything brings the bioeconomy to life...

Eben Bayer, founder of Ecovative, delves into the transformative power of mycelium technology and its potential to reshape industries from packaging to food production. He shares his journey from a small farm in Vermont to leading a company that pioneers sustainable materials, discussing how biology can be leveraged to create regenerative, profitable businesses. With a strong belief in the power of biology as technology, Eben explains how his innovations are not only environmentally friendly but also economically viable, offering a glimpse into the future of the bioeconomy.

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder...

Karl and Erum dig into the pivotal role of bio strategy in shaping the future of consumer products and sustainability. With insights into groundbreaking innovations—from Cresalon's trauma gel gaining FDA approval to Living Ink's partnership with New Balance—this discussion explores how biotech is transforming traditional industries. We also tackle the challenges of scaling bio-manufacturing, reducing costs, and navigating regulatory landscapes, all while highlighting the critical importance of integrating biology into corporate strategies. Join us as we uncover why now is the time for every company to adopt a bio strategy.

Grow Everything brings the bioeconomy to l...

Episode Description:

Erum and Karl welcome Deniz Kent to talk about the practical and innovative ways light is being used to control cellular processes, offering new possibilities in biotechnology. From sustainable fashion to the future of biomanufacturing, they discuss topics that impact both our personal lives and the broader scientific community. Deniz shares insights on using light-sensitive proteins to revolutionize biomanufacturing, potentially lowering costs and expanding access to life-saving drugs.

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world...

Episode Description:

Join us for an exciting live recording of the Grow Everything podcast, where we sit down with Ginger Dozier of Biomason to explore how microbes could change the world. From growing bricks to building a more sustainable future, Ginger shares her incredible journey and introduces her latest venture, BIOME Consortia, which is all about harnessing the power of biology to solve big problems. Supported by sponsors like MilliporeSigma, BioLabs, NYU Langone, and IndieBio, this episode dives into the fascinating intersection of biology and technology. If you’re curious about the future of biotech and how it...

Episode Description:

Karl and Erum are joined by Ari Wright from Bison VC to explore the world of biotechnology and its intersection with various industries. Ari shares her perspective on the controversial idea of the enhanced Olympics, where athletes use performance-enhancing drugs under medical supervision to push human limits. She discusses the potential of genetic engineering and CRISPR technology for both therapeutic and enhancement purposes and the importance of understanding microbiomes in trees to combat climate change. Ari also offers her expertise on investing in deep tech and femtech, addressing the need for commercial traction and the...

Episode Description:

Karl and Erum explore how Northern Queensland is transitioning from its historical reliance on coal mining to becoming a hub for bioeconomy. Kylie Porter, CEO of GW3 - Greater Whitsunday Alliance, shares insights on the region's rich agricultural roots, the innovative use of sugarcane in biotech, and the strategic efforts to build a sustainable future. The discussion highlights the significant role of community engagement and international collaborations in driving these changes. Tune in to hear about the exciting opportunities and challenges faced as the region redefines its economic landscape through biotechnology and sustainability initiatives.

Episode Description:

Karl and Erum have an informative conversation about the importance of networking. They discuss the philosophy behind building meaningful professional connections and share effective networking strategies. From insights into the concept of networking as an extension of human curiosity to tips like dividing and conquering at events, Karl and Erum give a comprehensive guide on enhancing your networking skills. They also talk about the idea of being generous and genuinely interested in others to foster stronger, more impactful relationships. Be sure to tune in if you’re looking to improve your networking approach and build a...

Episode Description:

Karl and Erum discuss the fascinating world of biomanufacturing with Michele Stansfield from Cauldron. They explore the groundbreaking potential of precision fermentation and its ability to revolutionize food, fiber, and fuel production. Michele shares insights on Cauldron’s innovative hyper fermentation technology, which offers a more sustainable and cost-effective alternative to traditional methods. The discussion also touches on the company's ambitious plans to build smaller, smarter biomanufacturing facilities globally, and the need for sustainable solutions in the face of growing food insecurity and environmental challenges. Tune in to learn how Cauldron is poised to transform th...

Episode Description:

Since it’s a holiday week, Karl and Erum are presenting a special replay of Edward Shenderovich’s episode. Edward Shenderovich, a seasoned entrepreneur and visionary in the biomanufacturing space, takes us through his journey into the heart of biotechnology and its potential to reshape industries. Edward discusses the inception of Synonym and its mission to revolutionize biomanufacturing by creating a cloud infrastructure that accelerates the path towards sustainable and profitable production. Through a conversation that spans entrepreneurship, the complexities of biology, and the future of biotech innovation, Edward shares invaluable insights into the challenges and...

Episode Description:

Karl and Erum are exploring the world of modern probiotics with Zack Abbott, co-founder of Z Biotics. They discuss the innovative approach Z Biotics takes in engineering probiotics to offer tangible benefits, specifically focusing on their flagship product designed to alleviate the unpleasant after-effects of alcohol consumption. Zack shares a look into the science behind their probiotic, explaining how it breaks down toxic byproducts in the gut, thereby improving the next-day experience after drinking. The conversation also touches on the broader implications of genetically modified organisms (GMOs) in consumer products, challenging common misconceptions and tells...

Episode Description:

Michael Fischer dives into the transformative impact of decentralized science (DeSci) on research and data sharing. He discusses the evolution of scientific research with the integration of blockchain technology, emphasizing how it democratizes access and incentivizes participation through tokenization. Fischer introduces WaterBear, a platform that gamifies science by creating community-driven research projects using meme coins, offering a fresh perspective on how data collection and validation can be more engaging and accessible. He also highlights various projects within WaterBear, such as SleepDAO and PsychedelicsDAO, showcasing their potential to revolutionize fields like sleep research and psychedelic studies...

Episode Description:

Charles Dimmler joins Karl and Erum once again to discuss the innovative intersections of biotechnology and sustainability at Checkerspot. The topics talked about range from the ethical considerations of animal testing in drug development to the revolutionary applications of CRISPR in creating more efficient drugs. Charles recounts the emotional and physical journey of testing WNDR Alpine, which gives you the gist of the real-world impact of Checkerspot's biotechnological advancements. Checkerspot also launched WTHR Skincare which has high performance ingredients derived from microalgae. This episode not only explains the company's approaches to tackling the challenges of...

Episode Description:

Karl and Erum transport us to the year 2054, offering a vibrant and thought-provoking portrayal of the future. They discuss advancements in AI, space travel, and biotechnology, painting a picture of a world completely evolved with rapid technological and biological innovations. From moon vacations to Mars exploration, the duo discusses the drastic changes in daily life and society. They talk about rewilding, the evolution of communication devices, and the integration of biology into leadership roles. Tune in to imagine the possibilities and reflect on the path ahead for humanity.

Grow Everything brings the bioeconomy...

Episode Description:

Karl and Erum discuss the state of health and technology with Laura Minquini of AthenaDAO, focusing on advancements in women's health research and quantum computing. Be sure to tune in to this conversation to hear about the importance of reproductive longevity, the challenges faced in women's health research, and the role of decentralized science.

Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything from sustainable ingredients to high performing materials. Biology is the oldest...

Episode Description:

Karl and Erum welcome Tony Kulesa, an engineer, investor, and entrepreneur in biotech. He’s sharing his insights on the future of biotechnology, discussing how advancements in reading and writing biology are driving significant changes in the field. Tony recounts his journey from academia to founding Petri, an incubator for biotech startups, and later integrating it into Pillar VC to support a global community of scientist-entrepreneurs. Tony emphasizes the importance of a supportive culture for transitioning academic research into practical, impactful solutions. The discussion covers the challenges and opportunities in biopharma, the potential of biotech in...

Episode Description:

Karl and Erum bring you the latest innovations highlighted at SynbioBeta 2024, focusing on the exciting intersection of AI and biotechnology. Hear about the groundbreaking work from the ARC Institute in whole genome sequencing and the newest advancements in AI-driven protein synthesis that are set to change the landscape of synthetic biology. They also touch on the potential of bioluminescent plants and the latest progress in space biomanufacturing. With expert insights and firsthand accounts from the conference, this episode offers a glimpse into the future of biotech and AI, sparking curiosity and excitement for what's to...

Episode Description:

Elliot Hershberg, a computational biologist, writer, and investor, joins Karl and Erum to explore the fascinating intersection of technology, biology, and philosophy. ​They explore the power of technology-based newsletters, the economics of fermentation, the role of AI in biology, and the future of biotech. The conversation raises thought-provoking questions about data reliability in AI-driven platforms and the need for cautious optimism in embracing new technologies. With insights into the minds of VCs and the potential implications of building a sentient AI, this episode offers a captivating glimpse into the exciting advancements and possibilities in the wo...

Episode Description:

Karl and Erum welcome Orr Yarkoni, CEO and co-founder of Colorifix. He gives us a deep look into the innovative realm of biotech and sustainable dyeing practices happening at Colorifix and the impact of conventional dyeing processes on the environment. Orr introduces a groundbreaking approach that utilizes genetically modified microorganisms to produce and fix dyes directly onto fabrics, highlighting significant reductions in water, chemical use, and energy consumption compared to traditional methods. This episode not only casts light on the urgent need for industry-wide adoption of eco-friendly technologies but also invites you to think about...

Episode Description:

Erum and Karl welcome renowned environmentalist, Murali Muthuswamy. He is the founder and chairman of Jananom Private Limited, founder of Elive Biotherapeutics USA, and advisor to Natural Nutrition. Murali explains the urgent and complex challenges of sustainable development. He also talks about the intricate balance required to meet the needs of the present without compromising the future. Exploring innovative solutions, Murali shines a light on groundbreaking technologies and community-driven initiatives that are paving the way for a more sustainable world. This episode not highlights the critical issues but also inspires action, making it a must-listen...

Episode Description:

Today’s interview is with Joe Landolina, the CEO and Co-founder of Cresilon, Inc. Karl, Erum, and Joe discuss the untapped potential of animal health markets and innovative cancer treatments. Joe shares his entrepreneurial journey from founding Cresilon, Inc. in his NYU dorm to developing Vetigel, a revolutionary product designed to rapidly halt bleeding in both animals and potentially humans. Their conversation not only highlights the critical role of biotech innovations in improving health outcomes but also underscores the vibrant ecosystem of investment and research propelling these advances forward. This episode is a must-listen if yo...

Episode Description:

Elizabeth Reynolds, Managing Director of Starburst Aerospace’s US business, takes us into the fascinating intersection of space exploration and biotechnology, discussing how advancements in space can propel innovations on Earth. Elizabeth explains the challenges of sustaining human life during long-duration space missions and the crucial role of biotech in creating self-sustaining environments for astronauts. From manufacturing pharmaceuticals in microgravity to exploring the potential of terraforming and asteroid mining, she explores a future where space travel and living are intertwined with biological advancements. Highlighting the collaborative spirit driving the space industry, today’s conversation illuminates the...

Episode Description:

Karl and Erum are diving into the world of Squitex, an innovative fabric born from the unique properties of squid teeth, with Melik Demirel, co-founder of Tandem Repeat and Huck endowed chair professor at Penn State. Melik shares his journey from exploring the depths of protein science to pioneering a sustainable solution that stands to revolutionize the textile industry. As they unpack the creation and potential of Squitex, Melik's insights illuminate the intersections of marine biology, biotechnology, and material science. This episode not only explores the technical marvels of Squitex, including its self-healing capabilities and...

Episode Description:

Karl and Erum take us into the nuanced world of networking within the biotech industry. They provide a fascinating look at the dos and don'ts of networking, illustrated through Erum's candid sharing of a cringeworthy recent networking event experience. Beyond just the mechanics, Karl and Erum explain the importance of offering value and the art of making meaningful connections. Whether you're a seasoned professional or new to the industry, this masterclass will equip you with strategies to move around in networking events successfully, fostering long-term relationships that go beyond mere transactions.

Grow Everything...

Episode Description:

Jackie Amable, CEO and co-founder of Matereal, shares her groundbreaking journey in revolutionizing the materials industry through sustainable innovation. She takes us right into the heart of environmental justice and technological advancements by laying out the story behind her venture into developing eco-friendly alternatives to harmful plastics. From her collaborative efforts to the profound impact on global supply chains, Jackie’s experiences and knowledge not only show how important and urgent it is to address plastic pollution but also displays the potential of biotech innovations to foster a more sustainable future. Join us as we ex...

Episode Description:

Today we are discussing the innovative intersection of synthetic biology and blockchain technology with Albert Anis, the visionary behind ValleyDAO. Anis shares his ambitious dream of creating a bioeconomy that is not owned by any single entity but is collectively governed by a community. Through the lens of ValleyDAO, we explore how decentralized autonomous organizations (DAOs) can fund, support, and propel scientific research in biotechnology, bringing it closer to the mainstream and potentially revolutionizing the way we approach the bioeconomy. Anis' passion for creating a shared, decentralized future where discoveries in synthetic biology can be...

Episode Description:

Dr. Tara Shirvani shares her rich knowledge about the transformative power of synthetic biology across various sectors, far beyond its roots in pharmaceuticals. With a passionate discussion ranging from the potential of algae biofuels to the innovative approaches towards addressing the climate crisis, Tara paints a vivid picture of a future where synthetic biology plays a crucial role in creating sustainable solutions for some of our planet's most pressing challenges. She delves into the critical importance of financing and policy support in scaling biotech innovations and underscores the untapped potential lying in the intersection of...

Episode Description: Ross McBee, co-founder and CSO of TomTex, takes us into the innovative world of biomaterials, showcasing his commitment to sustainability and eco-friendly solutions. By turning waste shrimp shells into versatile, biodegradable materials, McBee is not just proposing an alternative to traditional textiles but is pioneering a future where fashion and environmental stewardship go hand in hand. This discussion zeros in on the potential of biomaterials to reshape industries, emphasizing the importance of a holistic approach to sustainability that includes both ecological care and fair employment practices. McBee's vision for a more sustainable and ethically conscious world is...

Episode Description:

Edward Shenderovich, a seasoned entrepreneur and visionary in the biomanufacturing space, takes us through his journey into the heart of biotechnology and its potential to reshape industries. Edward discusses the inception of Synonym and its mission to revolutionize biomanufacturing by creating a cloud infrastructure that accelerates the path towards sustainable and profitable production. Through a conversation that spans entrepreneurship, the complexities of biology, and the future of biotech innovation, Edward shares invaluable insights into the challenges and opportunities that lie ahead in harnessing the power of biomanufacturing for global benefit. This episode is a deep...